However, our neutralization assays using residual sera with a profile suggesting priming with Wuhan-based COVID-19 vaccines and subsequent Omicron infection (W+BA2+ group) still induced neutralizing antibodies against BA.2. The gene discussed is CD9; the disease is COVID-19.